Jackson Walker Delivers Complete Defense Jury Verdict for Roku in $228 Million WDTX Patent Trial
Morningstar· 6 days agoAfter a four-day in-person trial, Jackson Walker delivered a complete defense jury verdict for Roku, Inc. Background Jackson Walker delivered a complete defense jury verdict for Roku in what ...
Inspur, China's largest cloud hardware vendor, joins open-sourcepatent protection consortium | ZDNet
ZDNet· 6 days agoThe Open Invention Network welcomes China's Inspur to its pro-Linux and open-source software patent...
Sanders, Senate Democrats Call on Biden to Support Covid-19 Vaccine Patent Waiver at WTO
CommonDreams.org· 4 days agoLed by South Africa and India and backed by more than 100 World Trade Organization (WTO) member...
Design Patent Examiner job with USAJobs | 42187177
Washington Post· 3 days agoCome work for the USPTO, we have been ranked as one of the best places to work in the federal government! The U.S. Patent and Trademark Office (USPTO) has been serving the ...
How to get COVID-19 vaccines to poor countries – and still keep patent benefits for drugmakers
The Conversation via Yahoo News· 5 days agoUnion rejected the idea, arguing that intellectual property rights – which give vaccine creators the...
Former world leaders urge Biden to waive COVID vaccine patents
Al Jazeera· 5 days agoIn an open letter shared by Oxfam on Wednesday, the signatories also urged Biden to support a...
InventHelp Inventor Presents a New Device to Aid in Transfer of Materials on Scaffolding (JKN-238)
DJournalnow· 2 hours agoThe invention had a patent pending and fulfills the need for a lifting apparatus for use with any erected scaffold. This portable invention eliminates the need to anchor and ...
Marshall federal jury sides with KeyMe in patent trial
The Marshall News Messenger· 2 days agoA federal jury in Marshall decided this week that KeyMe, a key duplication kiosk maker headquartered...
Stay in Your Lane: Defining the Scope of an IPR Deposition
The National Law Review· 3 days agoThe regulations governing discovery in an inter partes review ("IPR") proceeding do not provide for...
ERS Genomics Licenses CRISPR Patents to Nuvisan
GenomeWeb News· 13 hours agoNuvisan, based in Waltrop, Germany, will use ERS'w Genomics CRISPR-Cas9 portfolio to help advance its clients' drug discovery and early development programs.